Beranda › Leukemia Limfoblastik Akut › Minnesota
Uji klinis Leukemia Limfoblastik Akut di Minnesota
14 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- dan 48 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospitals and Clinics of Minnesota, Minneapolis
Menerima pesertaFase 2
Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519A Study of CTD402 in T-ALL/LBL Patients
- Mayo Clinic - Rochester, Rochester
Menerima pesertaFase 1/2
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07070219Allo HSCT Using RIC and PTCy for Hematological Diseases
- Masonic Cancer Center at University of Minnesota, Minneapolis
Menerima pesertaFase 2
Hingga usia 75 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05805605Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Masonic Cancer Center at University of Minnesota, Minneapolis
Menerima pesertaFase 2
Hingga usia 60 · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT03314974TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Children's Hospital of Minnesota, Minneapolis
Menerima pesertaFase 1/2
Hingga usia 1 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05848687Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
- University of Minnesota/Masonic Cancer Center, Minneapolis
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT05014165MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- University of Minnesota Masonic Cancer Center, Minneapolis
Menerima pesertaFase 2
Hingga usia 60 · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT05735717Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study
- Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Usia 2 hingga 22 · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT07071051Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
- Masonic Cancer Center, Minneapolis
Menerima pesertaStudi observasional
Usia 8 hingga 25 · Semua jenis kelamin · Diperbarui 24 Nov 2025 · NCT05025774Auto Stem Cell Transplant for Lymphoma Patients
- Masonic Cancer Center, University of Minnesota, Minneapolis
Menerima pesertaFase 2
Hingga usia 75 · Semua jenis kelamin · Diperbarui 4 Nov 2025 · NCT03125642Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- University of Minnesota, Minneapolis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital and Clinics of Minnesota, Minneapolis
Menerima pesertaFase 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.